Showing results (91-100 of 226) with videos related to
Sort By:
Pageof 23
Clinical Pharmacology and Therapeutics|July 5, 2003
Effect of fluconazole on the pharmacokinetics and pharmacodynamics of nateglinideMikko Niemi, Mikko Neuvonen, Laura Juntti-Patinen, et al.Clinical Pharmacology and Therapeutics|February 25, 2009
Effects of gemfibrozil and atorvastatin on the pharmacokinetics of repaglinide in relation to SLCO1B1 polymorphismA Kalliokoski, J T Backman, K J Kurkinen, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2002
Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomesJun-Sheng Wang, Mikko Neuvonen, Xia Wen, et al.Clinical Pharmacology and Therapeutics|June 15, 2001
Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizideM Niemi, J T Backman, M Neuvonen, et al.Clinical Pharmacology and Therapeutics|December 5, 2000
Rifampin decreases the plasma concentrations and effects of repaglinideM Niemi, J T Backman, M Neuvonen, et al.Journal of Clinical Pharmacology|April 20, 2010
Itraconazole, a P-glycoprotein and CYP3A4 inhibitor, markedly raises the plasma concentrations and enhances the renin-inhibiting effect of aliskirenTuija Tapaninen, Janne T Backman, Kaisa J Kurkinen, et al.British Journal of Clinical Pharmacology|October 1, 1994
The effect of erythromycin on the pharmacokinetics and pharmacodynamics of zopicloneK Aranko, H Luurila, J T Backman, et al.Basic & Clinical Pharmacology & Toxicology|July 7, 2005
Comparison of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) as inhibitors of cytochrome P450 2C8Aleksi Tornio, Marja K Pasanen, Jouko Laitila, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 3, 2012
Autoinhibition of CYP3A4 leads to important role of CYP2C8 in imatinib metabolism: variability in CYP2C8 activity may alter plasma concentrations and responseAnne M Filppula, Mikko Neuvonen, Jouko Laitila, et al.Clinical Pharmacology and Therapeutics|April 3, 2004
Fluvoxamine drastically increases concentrations and effects of tizanidine: a potentially hazardous interactionMarika T Granfors, Janne T Backman, Mikko Neuvonen, et al.Pageof 23